
Adept at strategic planning and cross-functional team leadership, I spearheaded global vaccine launches and medical affairs strategies at Pfizer, achieving significant public health impacts. My expertise in forecasting and verbal communication fostered key stakeholder relationships, driving innovative solutions and regulatory successes.
Authored almost 100 research papers and articles in peer-reviewed journals, including studies on antimicrobial resistance, infectious disease management, and vaccine efficacy.
Led and participated in multiple clinical trials, including studies on community-acquired pneumonia, catheter-related bloodstream infections, and hospital-acquired pneumonia.